Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. US Compounding Inc
483
•US Compounding Inc•March 27, 2014

US Compounding Inc – FDA 483, Mar 27, 2014

Record Details

An FDA Form 483 inspection revealed multiple deficiencies in the manufacturing of sterile drug products. The facility failed to ensure protective apparel was worn, as a technician had exposed skin in an ISO 5 laminar flow hood during Omnipaque setup. Procedures to prevent microbiological contamination were inadequate, with a technician unnecessarily hand-stoppering HCG/B12 vials in an ISO 5 hood.

Cleanliness was compromised, as ISO 5 laminar flow hoods contained white residue streaks, blotches, and amber residue on HEPA filters while sterile products were being produced. Container closure systems were deficient; finished Betamethasone vials were found soaking in an unvalidated solution without SOPs, risking contamination.

Sterility and pyrogen testing were non-conforming. The firm released multiple sterile lots using an unvalidated endotoxin test method by a contract lab, failing to provide product-specific dosing for maximum valid dilution calculation. Sterility testing suitability (USP <71>) was based on different products or formulations.

Drug product release lacked appropriate laboratory determination of conformance. No 100% visual or automated inspection of sterile finished products was documented, and no visual inspection procedure or technician training qualification existed.

Aseptic processing area cleaning and disinfection were deficient. Only one disinfectant ((b)(4)) was used in ISO 5 hoods, lacking a sporicidal agent. A pharmacy technician performed inadequate disinfection, only wiping the tabletop, ceiling, and sides, neglecting the stained back surface of

Company
US Compounding Inc
Inspection date
March 27, 2014
Office
Dallas District Office
People
  • Erika V. Butler (Compliance Officer / Investigator)
  • Kimberley A. Hoefen (Consumer Safety Officer )
View Company Profile

ID · 722e591e-6d7f-41cf-a2b3-93b2f590fba3

Violation Codes7
21 CFR 211.113(b)FD&C Act 801(a)(3)21 CFR 211.167(a)21 CFR 211.165(e)21 CFR 211.56(a)21 CFR 211.28(a)21 CFR 211.94(d)

Full citation text and observation details available on the Dashboard.

Other documents for US Compounding Inc
  • 483 - 2019-02-07February 7, 2019
  • 483 - 2016-07-15July 15, 2016
  • 483 - 2015-08-21August 21, 2015

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore US Compounding Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.